Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seng Gee Lim

Showing results (91-100 of 241) with videos related to

Pageof 25
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2024
Stopping Nucleos(t)ide Analogues in Chronic Hepatitis B Using HBsAg Thresholds: A Meta-Analysis and Meta-RegressionSeng Gee Lim, Ada Ee Der Teo, Edwin Shih-Yen Chan, et al.
Antiviral Therapy|December 13, 2012
Patient preferences for hepatitis B therapySeng Gee Lim, Myat Oo Aung, Stephanie W M Chung, et al.
Hepatology International|April 13, 2011
Risk factors for mortality in cirrhotic patients with sepsisLee-Guan Lim, Xiang-Xuan Eunice Tan, Shu-Jeng Woo, et al.
Antiviral Research|March 28, 2006
Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agentsTheresa May Chin Tan, Yu Chen, Kah Hoe Kong, et al.
Antiviral Research|January 13, 2006
Are in vitro hepatitis B core promoter mutations important for clinical alterations in viral load?Yan Cheng, Bee Leng Seet, Carmen Shair Ling Ong, et al.
Frontiers in Cellular and Infection Microbiology|June 8, 2026
HBx interacts with the host YBX3 protein and up-regulates its expression to mediate efficient Hepatitis B viral replicationMel Veen Boo, Jackie Chu, ZiJie Lim, et al.
Virology Journal|June 21, 2005
Genetic lesions within the 3a gene of SARS-CoVTimothy H P Tan, Timothy Barkham, Burtram C Fielding, et al.
Acta Oncologica (Stockholm, Sweden)|January 23, 2009
Lack of somatic mutations in VEGFR-2 tyrosine kinase domain in hepatocellular carcinomaBenjamin Y S Chuah, Wee-Lee Yeo, Jia Yi Guo, et al.
Journal of Gastroenterology and Hepatology|March 19, 2016
Cost-effectiveness of strategy-based approach to treatment of genotype 1 chronic hepatitis CYing Jiao Zhao, Ai Leng Khoo, Liang Lin, et al.
Gut and Liver|December 15, 2016
Magnetic Resonance Elastography and Diffusion Weighted Imaging in the Evaluation of Hepatic Fibrosis in Chronic Hepatitis BTiffany P Hennedige, Gang Wang, Fiona P Leung, et al.
Pageof 25

Showing results (91-100 of 241) with videos related to

Sort By:
Pageof 25
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2024
Stopping Nucleos(t)ide Analogues in Chronic Hepatitis B Using HBsAg Thresholds: A Meta-Analysis and Meta-RegressionSeng Gee Lim, Ada Ee Der Teo, Edwin Shih-Yen Chan, et al.
Antiviral Therapy|December 13, 2012
Patient preferences for hepatitis B therapySeng Gee Lim, Myat Oo Aung, Stephanie W M Chung, et al.
Hepatology International|April 13, 2011
Risk factors for mortality in cirrhotic patients with sepsisLee-Guan Lim, Xiang-Xuan Eunice Tan, Shu-Jeng Woo, et al.
Antiviral Research|March 28, 2006
Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agentsTheresa May Chin Tan, Yu Chen, Kah Hoe Kong, et al.
Antiviral Research|January 13, 2006
Are in vitro hepatitis B core promoter mutations important for clinical alterations in viral load?Yan Cheng, Bee Leng Seet, Carmen Shair Ling Ong, et al.
Frontiers in Cellular and Infection Microbiology|June 8, 2026
HBx interacts with the host YBX3 protein and up-regulates its expression to mediate efficient Hepatitis B viral replicationMel Veen Boo, Jackie Chu, ZiJie Lim, et al.
Virology Journal|June 21, 2005
Genetic lesions within the 3a gene of SARS-CoVTimothy H P Tan, Timothy Barkham, Burtram C Fielding, et al.
Acta Oncologica (Stockholm, Sweden)|January 23, 2009
Lack of somatic mutations in VEGFR-2 tyrosine kinase domain in hepatocellular carcinomaBenjamin Y S Chuah, Wee-Lee Yeo, Jia Yi Guo, et al.
Journal of Gastroenterology and Hepatology|March 19, 2016
Cost-effectiveness of strategy-based approach to treatment of genotype 1 chronic hepatitis CYing Jiao Zhao, Ai Leng Khoo, Liang Lin, et al.
Gut and Liver|December 15, 2016
Magnetic Resonance Elastography and Diffusion Weighted Imaging in the Evaluation of Hepatic Fibrosis in Chronic Hepatitis BTiffany P Hennedige, Gang Wang, Fiona P Leung, et al.
Pageof 25